Available at: https://goldcopd.org/wp-content/uploads/2020/07/GOLD_2021_REPORT_digital.pdf. Accessed on: Oct 15, 2023.2. Celli BR, et al. ATS guidelines: update on chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(5):532-555....
General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study. Swiss Med Wkly. Epub 2010 Apr 21... Anja,Jochmann,Falk,... - Swiss medical weekly: official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine...
GOLD 推荐的 COPD 治疗药品有 46 种,其中 38 种在我 国上市.相较于国内临床治疗指南而言,GOLD 多收录 了 1 种 COPD 三联复合制剂——倍氯米松/福莫特罗/格 隆溴铵(倍氯福格),但 GOLD 收录的祛痰药及抗氧化剂 种类较少.国家医保目录共覆盖 COPD 治疗药品 46 种, 三联复合制剂在 2023 年被首次纳入医保...
https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf 7. Cox NS, Oliveira CC, Lahham A, Holland AE. Pulmonary rehabilitation referral and participation are commonly influenced by environment, knowledge, and beliefs about consequences: a systematic...
Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollutiondoi:10.12659/MSM.942672Parums, Dinah V.Medical Science Monitor
GOLD guidelines classify COPD patients into A-D groups based on health status as assessed by COPD Assessment Test (CAT) or mMRC tools and exacerbations and... Ioanna,Tsiligianni,Maria,... - 《International Journal of Chronic Obstructive Pulmonary Disease》 被引量: 0发表: 2019年 Clinical and ...
In addition, according to the current GOLD guidelines, ICS should not be used in patients assessed as being in GOLD Group A or B, i.e. patients who have not yet experienced an exacerbation, unless the patient has asthma as a comorbidity [1]....
2014年,全球哮喘防治倡议 (GINA) 和GOLD相继提出哮喘慢阻肺重叠综合征 (ACOS) 的概念,3年后,2017 GOLD和GINA指南再次进行重大修订,直接放弃ACOS的概念,取而代之的是哮喘慢阻肺重叠 (ACO) 。 2020版GOLD指南不再提哮喘-慢阻肺重叠,对此,小编有疑惑了,是否意味着通过之前的指南诊断患有ACOS和ACO的患者是有偏差...
It would appear, then, that the new ATS guidelines contradict GOLD. GOLD specifically recommends going to dual and then triple therapy for patients on monotherapy with persistent symptoms. In fact, the 2020 GOLD document has a separate flow chart for dyspnea that seems to directly contradict the...
Variation in adherence with global initiative for chronic obstructive lung disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis Curr. Med. Res. Opin., 27 (7) (2011), pp. 1425-1429 CrossrefView in ScopusGoogle Scholar [42] K. Krigsman, J.L. Nilsson, L. ...